BREANNA HILL: Open Payments
NPI 1467107284 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 50 payments from 22 companies in 2025. Trend: 2023 $1,714 · 2024 $1,492 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $154 |
| Novartis Pharmaceuticals Corporation | 7 | $142 |
| ABBVIE INC. | 5 | $136 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| GlaxoSmithKline, LLC. | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $62 |
| Celgene Corporation | 2 | $60 |
| Daiichi Sankyo Inc. | 2 | $60 |
| Gilead Sciences, Inc. | 2 | $50 |
Products named: IMBRUVICA, FRUZAQLA, KEYTRUDA, OPDIVO, Xtandi, REBLOZYL, Enhertu, JEMPERLI.
Industry payments across FL — which companies pay providers there.
